Page last updated: 2024-08-21

tripalmitin and Hemolysis

tripalmitin has been researched along with Hemolysis in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Amore, E; Augello, G; Bondì, ML; Botto, C; Cervello, M; Craparo, EF; Emma, MR1

Other Studies

1 other study(ies) available for tripalmitin and Hemolysis

ArticleYear
Lipid nanocarriers containing sorafenib inhibit colonies formation in human hepatocarcinoma cells.
    International journal of pharmaceutics, 2015, Sep-30, Volume: 493, Issue:1-2

    Topics: Antineoplastic Agents; Caprylates; Cell Survival; Chromatography, High Pressure Liquid; Delayed-Action Preparations; Drug Carriers; Drug Liberation; Hemolysis; Hep G2 Cells; Humans; Lipids; Microscopy, Electron, Scanning; Nanoparticles; Niacinamide; Particle Size; Phenylurea Compounds; Sorafenib; Triglycerides

2015